Cargando…
Prospective Cohort Study with Active Surveillance for Fever in Four Dengue Endemic Countries in Latin America
To prepare for a Phase III dengue vaccine efficacy trial, 20 investigational sites were selected for this observational study to identify dengue infections in a closed cohort (N = 3,000 children 9–16 years of age). Of 255 acute febrile episodes experienced by 235 children, 50 (21.3%) were considered...
Autores principales: | Dayan, Gustavo, Arredondo, Jose L., Carrasquilla, Gabriel, Deseda, Carmen C., Dietze, Reynaldo, Luz, Kleber, Costa, Maria Selma N., Cunha, Rivaldo V., Rey, Luis C., Morales, Javier, Reynales, Humberto, Miranda, Maria, Zambrano, Betzana, Rivas, Enrique, Garbes, Pedro, Noriega, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Tropical Medicine and Hygiene
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497892/ https://www.ncbi.nlm.nih.gov/pubmed/26013373 http://dx.doi.org/10.4269/ajtmh.13-0663 |
Ejemplares similares
-
Zika and Dengue Interactions in the Context of a Large Dengue Vaccine Clinical Trial in Latin America
por: Zambrano, Betzana, et al.
Publicado: (2021) -
Secondary Analysis of the Efficacy and Safety Trial Data of the Tetravalent Dengue Vaccine in Children and Adolescents in Colombia
por: Reynales, Humberto, et al.
Publicado: (2020) -
Immunogenicity and Safety of a Recombinant Tetravalent Dengue Vaccine in Children and Adolescents Ages 9–16 Years in Brazil
por: Dayan, Gustavo H., et al.
Publicado: (2013) -
Analysis of Hospitalized and Severe Dengue Cases Over the 6 years of Follow-up of the Tetravalent Dengue Vaccine (CYD-TDV) Efficacy Trials in Asia and Latin America
por: Forrat, Rémi, et al.
Publicado: (2021) -
Economic Impact of Dengue Illness in the Americas
por: Shepard, Donald S., et al.
Publicado: (2011)